Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SCYX

SCYX News

Newswire

09:34

Scynexis shares surge 16.95% intraday after completing BREXAFEMME NDA transfer to GSK, enabling FDA interactions and future royalties.

07:11

GSK completes BREXAFEMME NDA transfer, to receive $145.5mln milestones and royalties.

07:00

SCYNEXIS Completes Transfer of BREXAFEMME NDA to GSK; Receives $145.5M Milestones, Royalties upon Relaunch

10:18

SCYNEXIS Receives $7M Grant for Antifungal Therapeutics Development.

10:15

New Therapeutics for Resistant Fungal Infections Receive $7 Million Federal Grant Funding

View More

About SCYX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More